Xr Securities LLC Celldex Therapeutics, Inc. Transaction History
Xr Securities LLC
- $5.35 Billion
- Q4 2024
A detailed history of Xr Securities LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Xr Securities LLC holds 5,200 shares of CLDX stock, worth $127,347. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,200Holding current value
$127,347% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CLDX
# of Institutions
199Shares Held
65.9MCall Options Held
1.68MPut Options Held
980K-
Wellington Management Group LLP Boston, MA9.24MShares$226 Million0.06% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$115 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.87MShares$94.8 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.46MShares$84.7 Million9.64% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$81.6 Million1.99% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.15B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...